NanoGroup S.A. (NNG.WA)

PLN 3.54

(11.15%)

EBITDA Summary of NanoGroup S.A.

NanoGroup S.A.'s latest annual EBITDA in 2023 was -7.87 Million PLN , down -992.64% from previous year.
NanoGroup S.A.'s latest quarterly EBITDA in 2024 Q2 was -1.34 Million PLN , down -4.35% from previous quarter.
NanoGroup S.A. reported an annual EBITDA of -719.95 Thousand PLN in 2022, up 86.94% from previous year.
NanoGroup S.A. reported an annual EBITDA of -10.62 Million PLN in 2021, down -8.0% from previous year.
NanoGroup S.A. reported a quarterly EBITDA of -1.28 Million PLN for 2024 Q1, up 55.03% from previous quarter.
NanoGroup S.A. reported a quarterly EBITDA of -1.47 Million PLN for 2023 Q3, up 9.82% from previous quarter.

Annual EBITDA Chart of NanoGroup S.A. (2023 - 2015)

Historical Annual EBITDA of NanoGroup S.A. (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-7.87 Million PLN	-992.64%
2022	-719.95 Thousand PLN	86.94%
2021	-10.62 Million PLN	-8.0%
2020	-5.05 Million PLN	-241.56%
2019	-1.27 Million PLN	36.38%
2018	-2.64 Million PLN	-19.95%
2017	-2.2 Million PLN	-117.42%
2016	-784.6 Thousand PLN	-47.69%
2015	-609.62 Thousand PLN	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-1.34 Million PLN	-4.35%
2024 Q1	-1.28 Million PLN	55.03%
2023 Q3	-1.47 Million PLN	9.82%
2023 Q1	-1.83 Million PLN	-158.93%
2023 Q2	-1.63 Million PLN	10.73%
2023 FY	- PLN	-2205.39%
2023 Q4	-2.85 Million PLN	-93.47%
2022 Q2	-849.13 Thousand PLN	48.54%
2022 FY	- PLN	86.94%
2022 Q4	3.11 Million PLN	333.17%
2022 Q3	-1.33 Million PLN	-57.35%
2022 Q1	-1.65 Million PLN	75.77%
2021 Q1	-1.05 Million PLN	75.34%
2021 Q2	-1.63 Million PLN	-54.92%
2021 FY	- PLN	-8.0%
2021 Q3	-1.11 Million PLN	31.89%
2021 Q4	-6.8 Million PLN	-509.66%
2020 Q2	-236.08 Thousand PLN	43.15%
2020 Q1	-415.27 Thousand PLN	32.16%
2020 FY	- PLN	-241.56%
2020 Q4	-4.29 Million PLN	-3734.05%
2020 Q3	-111.96 Thousand PLN	52.58%
2019 Q2	-379.96 Thousand PLN	-226.68%
2019 Q1	-116.31 Thousand PLN	49.62%
2019 FY	- PLN	36.38%
2019 Q3	-162.68 Thousand PLN	57.18%
2019 Q4	-612.09 Thousand PLN	-276.25%
2018 Q2	-852.77 Thousand PLN	-5.46%
2018 Q3	-455.89 Thousand PLN	46.54%
2018 FY	- PLN	-19.95%
2018 Q4	-230.84 Thousand PLN	49.36%
2018 Q1	-808.62 Thousand PLN	-8.77%
2017 Q2	-416.98 Thousand PLN	8.28%
2017 FY	- PLN	-117.42%
2017 Q3	-341.34 Thousand PLN	18.14%
2017 Q1	-454.65 Thousand PLN	0.0%
2017 Q4	-743.44 Thousand PLN	-117.8%
2016 FY	- PLN	-47.69%
2015 FY	- PLN	0.0%

Peer EBITDA Comparison of NanoGroup S.A.

Name	EBITDA	EBITDA Difference
Bioceltix S.A.	-13.22 Million PLN	40.487%
BIOTON S.A.	43.89 Million PLN	117.929%
Captor Therapeutics Spolka Akcyjna	-64.76 Million PLN	87.848%
Mabion S.A.	58.31 Million PLN	113.497%
Molecure S.A.	-25.5 Million PLN	69.143%
Pharmena S.A.	33.78 Million PLN	123.299%
Poltreg S.A.	-11.65 Million PLN	32.496%
Pure Biologics Spólka Akcyjna	-26.07 Million PLN	69.819%
Ryvu Therapeutics S.A.	-81.04 Million PLN	90.289%
Synthaverse S.A.	15.34 Million PLN	151.285%
Urteste S.A.	-5.73 Million PLN	-37.328%